CFRA Downgrades Novo Nordisk (NVO) to Sell
Tweet
Share
E-mail
Get Alerts NVO Hot Sheet
Price: $38.47 -2.36%
Rating Summary:
8 Buy, 16 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
8 Buy, 16 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
CFRA analyst Wan Nurhayati downgraded Novo Nordisk (NYSE: NVO) from Hold to Sell with a price target of $38.00.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $39.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
- Scotiabank Reiterates Sector Outperform Rating on Capstone Copper Corp (CS:CN) (CSFFF)
- Darden Restaurants (DRI) call put ratio 1.1 calls to 1 put into the expected release of quarter results
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
